Lista de obras - Eugenio Pucci - Dominio Público Uruguay

Absence of HHV-6 and HHV-7 in cerebrospinal fluid in relapsing-remitting multiple sclerosis

artículo científico publicado en 2000

Amantadine for fatigue in multiple sclerosis

artículo científico publicado en 2007

Amantadine for fatigue in multiple sclerosis

artículo científico publicado en 2003

Aminopyridines for symptomatic treatment in multiple sclerosis

artículo científico publicado en 2001

An EEG power index (eyes open vs. eyes closed) to differentiate Alzheimer's from vascular dementia and healthy ageing

scientific article published on 01 May 1996

An information aid for newly diagnosed multiple sclerosis patients improves disease knowledge and satisfaction with care

artículo científico publicado en 2010

Anti-inflammatory disease-modifying treatment and short-term disability progression in SPMS.

artículo científico publicado en 2017

BREMSO: a simple score to predict early the natural course of multiple sclerosis.

artículo científico publicado en 2015

Communicating the diagnosis of multiple sclerosis - a qualitative study

scientific article published on 15 March 2007

Comparative effectiveness of glatiramer acetate and interferon beta formulations in relapsing-remitting multiple sclerosis

artículo científico publicado en 2014

Comparative efficacy of first-line natalizumab vs IFN-β or glatiramer acetate in relapsing MS.

artículo científico publicado en 2016

Comparison of switch to fingolimod or interferon beta/glatiramer acetate in active multiple sclerosis

artículo científico publicado en 2015

Computer-aided retraining of memory and attention in people with multiple sclerosis: a randomized, double-blind controlled trial

artículo científico publicado en 2004

Conscience clause in end-of-life care

artículo científico publicado en 2017

Contribution of different relapse phenotypes to disability in multiple sclerosis.

artículo científico publicado en 2016

Cytochemistry of intraplatelet Ca++ spots as a peripheral marker of age-related brain impairment

artículo científico publicado en 2000

Data quality evaluation for observational multiple sclerosis registries

artículo científico publicado en 2016

Defining reliable disability outcomes in multiple sclerosis

artículo científico publicado en 2015

Defining secondary progressive multiple sclerosis

artículo científico publicado en 2016

Development of an ELISA Test for Determination of the Urinary Trypsin Inhibitor: Analytical Performance and Applications

artículo científico publicado en 2005

Diagnosing Alzheimer's disease: from research to clinical practice and ethics

artículo científico publicado en 2014

Discontinuing disease-modifying therapy in MS after a prolonged relapse-free period: a propensity score-matched study

artículo científico publicado en 2016

EEG power spectrum differences in early and late onset forms of Alzheimer's disease

artículo científico publicado en 1999

EEG power spectrum typical of vascular dementia in a subgroup of Alzheimer patients

artículo científico publicado en 1996

EEG spectral analysis in Alzheimer's disease and different degenerative dementias

artículo científico publicado en 1998

EEG spectral analysis in vascular and Alzheimer dementia

artículo científico publicado en 1995

Ethical issues in end of life treatments for patients with dementia

artículo científico publicado en 2010

Ethical questions in the treatment of subjects with dementia. Part I. Respecting autonomy: awareness, competence and behavioural disorders

artículo científico publicado en 2007

General practitioners facing dementia: are they fully prepared?

artículo científico publicado en 2004

Higher latitude is significantly associated with an earlier age of disease onset in multiple sclerosis.

artículo científico publicado en 2016

Highly active immunomodulatory therapy ameliorates accumulation of disability in moderately advanced and advanced multiple sclerosis

artículo científico publicado en 2016

Hippocampus and parahippocampal gyrus linear measurements based on magnetic resonance in Alzheimer's disease

artículo científico publicado en 1998

Information and competency for consent to pharmacologic clinical trials in Alzheimer disease: an empirical analysis in patients and family caregivers

artículo científico publicado en 2001

Is the internet transforming the physician-consumer relationship? Preliminary data in a neurological setting

artículo científico publicado en 2003

Italian version of the Chicago multiscale depression inventory: translation, adaptation and testing in people with multiple sclerosis

artículo científico publicado en 2004

Lack of Chlamydia infection of the central nervous system in multiple sclerosis

artículo científico publicado en 2000

Long-term disability trajectories in primary progressive MS patients: A latent class growth analysis

artículo científico publicado en 2017

Message for caregivers of dementia with Lewy bodies patients: hallucinations can be pleasurable for your patient. Cope with your embarrassment and empathize

artículo científico publicado en 2006

Natalizumab for relapsing remitting multiple sclerosis

artículo científico publicado en 2011

Natalizumab for relapsing remitting multiple sclerosis

artículo científico publicado en 2009

Natalizumab treatment in multiple sclerosis patients: a multicenter experience in clinical practice in Italy

artículo científico publicado en 2014

Need for palliative care for neurological diseases

artículo científico publicado en 2016

Participation in medical decision-making: attitudes of Italians with multiple sclerosis

artículo científico publicado en 2008

Percutaneous transluminal angioplasty for treatment of chronic cerebrospinal venous insufficiency (CCSVI) in multiple sclerosis patients

artículo científico publicado en 2012

Percutaneous transluminal angioplasty for treatment of chronic cerebrospinal venous insufficiency in people with multiple sclerosis: a summary of a Cochrane systematic review.

artículo científico publicado en 2013

Persistent vegetative state: an ethical reappraisal

artículo científico publicado en 2011

Predictors of long-term disability accrual in relapse-onset multiple sclerosis

artículo científico publicado en 2016

Prognostic indicators in pediatric clinically isolated syndrome

artículo científico publicado en 2017

Quantifying risk of early relapse in patients with first demyelinating events: Prediction in clinical practice.

artículo científico publicado en 2016

Responsiveness of patient reported outcome measures in multiple sclerosis relapses: the REMS study

artículo científico publicado en 2009

Risk of early relapse following the switch from injectables to oral agents for multiple sclerosis

artículo científico publicado en 2016

Risk-benefit considerations in the treatment of relapsing-remitting multiple sclerosis ⬇️

artículo científico publicado el 24 de junio de 2013

Safety and tolerability in relapsing-remitting multiple sclerosis patients treated with high-dose subcutaneous interferon-beta by Rebiject autoinjection over a 1-year period: the CoSa study

artículo científico publicado en 2008

Switch to natalizumab versus fingolimod in active relapsing-remitting multiple sclerosis

artículo científico publicado en 2015

The effect of oral immunomodulatory therapy on treatment uptake and persistence in multiple sclerosis

artículo científico publicado en 2015

Topographical disorientation consequent to amnesia of spatial location in a patient with right parahippocampal damage

scientific article published on 01 June 2000

Treatment effectiveness of alemtuzumab compared with natalizumab, fingolimod, and interferon beta in relapsing-remitting multiple sclerosis: a cohort study.

artículo científico publicado en 2017

Understanding information on clinical trials by persons with Alzheimer's dementia. A pilot study

artículo científico publicado en 2009

What do Italians at high risk of stroke know about ischaemic stroke? A survey among a group of subjects undergoing neuro-sonographic examination

artículo científico publicado en 2006

Why physicians need to look more closely at the use of complementary and alternative medicine by multiple sclerosis patients

artículo científico publicado en 2004

Lista de obras de Eugenio Pucci

Absence of HHV-6 and HHV-7 in cerebrospinal fluid in relapsing-remitting multiple sclerosis

Amantadine for fatigue in multiple sclerosis

Amantadine for fatigue in multiple sclerosis

Aminopyridines for symptomatic treatment in multiple sclerosis

An EEG power index (eyes open vs. eyes closed) to differentiate Alzheimer's from vascular dementia and healthy ageing

An information aid for newly diagnosed multiple sclerosis patients improves disease knowledge and satisfaction with care

Anti-inflammatory disease-modifying treatment and short-term disability progression in SPMS.

BREMSO: a simple score to predict early the natural course of multiple sclerosis.

Communicating the diagnosis of multiple sclerosis - a qualitative study

Comparative effectiveness of glatiramer acetate and interferon beta formulations in relapsing-remitting multiple sclerosis

Comparative efficacy of first-line natalizumab vs IFN-β or glatiramer acetate in relapsing MS.

Comparison of switch to fingolimod or interferon beta/glatiramer acetate in active multiple sclerosis

Computer-aided retraining of memory and attention in people with multiple sclerosis: a randomized, double-blind controlled trial

Conscience clause in end-of-life care

Contribution of different relapse phenotypes to disability in multiple sclerosis.

Cytochemistry of intraplatelet Ca++ spots as a peripheral marker of age-related brain impairment

Data quality evaluation for observational multiple sclerosis registries

Defining reliable disability outcomes in multiple sclerosis

Defining secondary progressive multiple sclerosis

Development of an ELISA Test for Determination of the Urinary Trypsin Inhibitor: Analytical Performance and Applications

Diagnosing Alzheimer's disease: from research to clinical practice and ethics

Discontinuing disease-modifying therapy in MS after a prolonged relapse-free period: a propensity score-matched study

EEG power spectrum differences in early and late onset forms of Alzheimer's disease

EEG power spectrum typical of vascular dementia in a subgroup of Alzheimer patients

EEG spectral analysis in Alzheimer's disease and different degenerative dementias

EEG spectral analysis in vascular and Alzheimer dementia

Ethical issues in end of life treatments for patients with dementia

Ethical questions in the treatment of subjects with dementia. Part I. Respecting autonomy: awareness, competence and behavioural disorders

General practitioners facing dementia: are they fully prepared?

Higher latitude is significantly associated with an earlier age of disease onset in multiple sclerosis.

Highly active immunomodulatory therapy ameliorates accumulation of disability in moderately advanced and advanced multiple sclerosis

Hippocampus and parahippocampal gyrus linear measurements based on magnetic resonance in Alzheimer's disease

Information and competency for consent to pharmacologic clinical trials in Alzheimer disease: an empirical analysis in patients and family caregivers

Is the internet transforming the physician-consumer relationship? Preliminary data in a neurological setting

Italian version of the Chicago multiscale depression inventory: translation, adaptation and testing in people with multiple sclerosis

Lack of Chlamydia infection of the central nervous system in multiple sclerosis

Long-term disability trajectories in primary progressive MS patients: A latent class growth analysis

Message for caregivers of dementia with Lewy bodies patients: hallucinations can be pleasurable for your patient. Cope with your embarrassment and empathize

Natalizumab for relapsing remitting multiple sclerosis

Natalizumab for relapsing remitting multiple sclerosis

Natalizumab treatment in multiple sclerosis patients: a multicenter experience in clinical practice in Italy

Need for palliative care for neurological diseases

Participation in medical decision-making: attitudes of Italians with multiple sclerosis

Percutaneous transluminal angioplasty for treatment of chronic cerebrospinal venous insufficiency (CCSVI) in multiple sclerosis patients

Percutaneous transluminal angioplasty for treatment of chronic cerebrospinal venous insufficiency in people with multiple sclerosis: a summary of a Cochrane systematic review.

Persistent vegetative state: an ethical reappraisal

Predictors of long-term disability accrual in relapse-onset multiple sclerosis

Prognostic indicators in pediatric clinically isolated syndrome

Quantifying risk of early relapse in patients with first demyelinating events: Prediction in clinical practice.

Responsiveness of patient reported outcome measures in multiple sclerosis relapses: the REMS study

Risk of early relapse following the switch from injectables to oral agents for multiple sclerosis

Risk-benefit considerations in the treatment of relapsing-remitting multiple sclerosis ⬇️

Safety and tolerability in relapsing-remitting multiple sclerosis patients treated with high-dose subcutaneous interferon-beta by Rebiject autoinjection over a 1-year period: the CoSa study

Switch to natalizumab versus fingolimod in active relapsing-remitting multiple sclerosis

The effect of oral immunomodulatory therapy on treatment uptake and persistence in multiple sclerosis

Topographical disorientation consequent to amnesia of spatial location in a patient with right parahippocampal damage

Treatment effectiveness of alemtuzumab compared with natalizumab, fingolimod, and interferon beta in relapsing-remitting multiple sclerosis: a cohort study.

Understanding information on clinical trials by persons with Alzheimer's dementia. A pilot study

What do Italians at high risk of stroke know about ischaemic stroke? A survey among a group of subjects undergoing neuro-sonographic examination

Why physicians need to look more closely at the use of complementary and alternative medicine by multiple sclerosis patients